These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 9709909)

  • 41. [Pregnancy and the thyroid gland].
    Lieutaud H
    Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histologic Findings and Cytological Alterations in Thyroid Nodules After Radioactive Iodine Treatment for Graves' Disease: A Diagnostic Dilemma.
    El Hussein S; Omarzai Y
    Int J Surg Pathol; 2017 Jun; 25(4):314-318. PubMed ID: 28201927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of Marine-Lenhart syndrome on
    Agrawal K; Patro PSS; Meher BR; Gnanasegaran G
    World J Nucl Med; 2021; 20(4):369-373. PubMed ID: 35018152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
    Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma.
    Senyurek Giles Y; Tunca F; Boztepe H; Kapran Y; Terzioglu T; Tezelman S
    Surgery; 2008 Dec; 144(6):1028-36; discussion 1036-7. PubMed ID: 19041014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T3-release from autonomously functioning thyroid nodules in vitro.
    Poertl S; Kirner J; Saller B; Mann K; Hoermann R
    Exp Clin Endocrinol Diabetes; 1998; 106(6):489-93. PubMed ID: 10079030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls.
    Centeno BA; Szyfelbein WM; Daniels GH; Vickery AL
    Acta Cytol; 1996; 40(6):1189-97. PubMed ID: 8960027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased aggressiveness of thyroid cancer in patients with Graves' disease.
    Belfiore A; Garofalo MR; Giuffrida D; Runello F; Filetti S; Fiumara A; Ippolito O; Vigneri R
    J Clin Endocrinol Metab; 1990 Apr; 70(4):830-5. PubMed ID: 2180978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High Rates of Underlying Thyroid Cancer in Patients Undergoing Thyroidectomy for Hyperthyroidism.
    Alvarez AL; Mulder M; Handelsman RS; Lew JI; Farra JC
    J Surg Res; 2020 Jan; 245():523-528. PubMed ID: 31450040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome of antithyroid medication and radioiodine therapy in pediatric Graves' disease.
    Leu SW; Chi CS; Shu SG
    Acta Paediatr Taiwan; 2003; 44(4):220-6. PubMed ID: 14674226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-diagnostic fine needle aspiration biopsy: a dilemma in management of nodular thyroid disease.
    McHenry CR; Walfish PG; Rosen IB
    Am Surg; 1993 Jul; 59(7):415-9. PubMed ID: 8323073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperthyroidism. Current treatment guidelines.
    Gittoes NJ; Franklyn JA
    Drugs; 1998 Apr; 55(4):543-53. PubMed ID: 9561343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Thyroid nodule in Basedow-Graves disease and thyroid cancer: experience in 6 patients].
    Piraino P; Sepúlveda A; Ibarra A; Michelsen H; Gac A; Pumarino H
    Rev Med Chil; 1995 Nov; 123(11):1402-8. PubMed ID: 8733284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of Graves' disease in the development of thyroid nodules and thyroid cancer.
    Soares MN; Borges-Canha M; Neves C; Neves JS; Carvalho D
    Eur Thyroid J; 2023 Jul; 12(4):. PubMed ID: 37235699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
    Mihai R; Parker AJ; Roskell D; Sadler GP
    Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Basedow's disease associated with benign and malignant nodular disease of the thyroid: diagnosis and treatment].
    Erdas E; Licheri S; Pisano G; Pomata M; Daniele GM
    Chir Ital; 2004; 56(2):175-84. PubMed ID: 15152509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.